199 related articles for article (PubMed ID: 33502641)
1. Low-dose antiplatelet therapy survey after intracerebral hemorrhage in China: a retrospective hospital-based study.
Ma X; Liu D; Niu S; Zhao W; Song X; Li C; Zhou L; Ma J; Jia W
Neurosurg Rev; 2021 Oct; 44(5):2923-2931. PubMed ID: 33502641
[TBL] [Abstract][Full Text] [Related]
2. Antiplatelet Resumption after Antiplatelet-Related Intracerebral Hemorrhage: A Retrospective Hospital-Based Study.
Teo KC; Lau GKK; Mak RHY; Leung HY; Chang RSK; Tse MY; Lee R; Leung GKK; Ho SL; Cheung RTF; Siu DCW; Chan KH
World Neurosurg; 2017 Oct; 106():85-91. PubMed ID: 28606579
[TBL] [Abstract][Full Text] [Related]
3. Clinical effects of restarting antiplatelet therapy in patients with intracerebral hemorrhage.
Jung NY; Cho J
Clin Neurol Neurosurg; 2022 Sep; 220():107361. PubMed ID: 35835024
[TBL] [Abstract][Full Text] [Related]
4. Effects of Antiplatelet Therapy After Stroke Caused by Intracerebral Hemorrhage: Extended Follow-up of the RESTART Randomized Clinical Trial.
Al-Shahi Salman R; Dennis MS; Sandercock PAG; Sudlow CLM; Wardlaw JM; Whiteley WN; Murray GD; Stephen J; Rodriguez A; Lewis S; Werring DJ; White PM;
JAMA Neurol; 2021 Oct; 78(10):1179-1186. PubMed ID: 34477823
[TBL] [Abstract][Full Text] [Related]
5. Prescribing antiplatelet medicine and subsequent events after intracerebral hemorrhage.
Flynn RW; MacDonald TM; Murray GD; MacWalter RS; Doney AS
Stroke; 2010 Nov; 41(11):2606-11. PubMed ID: 20947854
[TBL] [Abstract][Full Text] [Related]
6. Effect of antiplatelet therapy on the incidence, prognosis, and rebleeding of intracerebral hemorrhage.
Li Y; Liu X; Chen S; Wang J; Pan C; Li G; Tang Z
CNS Neurosci Ther; 2023 Jun; 29(6):1484-1496. PubMed ID: 36942509
[TBL] [Abstract][Full Text] [Related]
7. Antiplatelet Treatment After Transient Ischemic Attack and Ischemic Stroke in Patients With Cerebral Microbleeds in 2 Large Cohorts and an Updated Systematic Review.
Lau KK; Lovelock CE; Li L; Simoni M; Gutnikov S; Küker W; Mak HKF; Rothwell PM
Stroke; 2018 Jun; 49(6):1434-1442. PubMed ID: 29748422
[TBL] [Abstract][Full Text] [Related]
8. Early Antiplatelet Resumption and the Risks of Major Bleeding After Intracerebral Hemorrhage.
Liu CH; Wu YL; Hsu CC; Lee TH
Stroke; 2023 Feb; 54(2):537-545. PubMed ID: 36621820
[TBL] [Abstract][Full Text] [Related]
9. Long-term outcome after anticoagulation-associated intracerebral haemorrhage with or without restarting antithrombotic therapy.
Gathier CS; Algra A; Rinkel GJ; van der Worp HB
Cerebrovasc Dis; 2013; 36(1):33-7. PubMed ID: 23920426
[TBL] [Abstract][Full Text] [Related]
10. Antiplatelet Therapy after Intracerebral Hemorrhage and Subsequent Clinical Events: A 12-Year South Korean Cohort Study.
Moon JY; Lee JG; Kim JH
Eur Neurol; 2021; 84(3):183-191. PubMed ID: 33831859
[TBL] [Abstract][Full Text] [Related]
11. Antithrombotic Treatment Following Intracerebral Hemorrhage in Patients With and Without Atrial Fibrillation.
Pennlert J; Asplund K; Carlberg B; Wiklund PG; Wisten A; Åsberg S; Eriksson M
Stroke; 2015 Aug; 46(8):2094-9. PubMed ID: 26159794
[TBL] [Abstract][Full Text] [Related]
12. Antiplatelet Agent Use After Stroke due to Intracerebral Hemorrhage.
Al-Shahi Salman R; Greenberg SM
Stroke; 2023 Dec; 54(12):3173-3181. PubMed ID: 37916459
[TBL] [Abstract][Full Text] [Related]
13. Five-Year Risk of Major Ischemic and Hemorrhagic Events After Intracerebral Hemorrhage.
Casolla B; Moulin S; Kyheng M; Hénon H; Labreuche J; Leys D; Bauters C; Cordonnier C
Stroke; 2019 May; 50(5):1100-1107. PubMed ID: 31009357
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular and cerebrovascular events in patients with intracerebral hemorrhage: Clinical characteristics and long-term predictors.
Jiang G; Cai H; Wen X; Chen K; Li H; Zhang Y; Yang Y; Chen J; Chen L
J Clin Neurosci; 2021 Aug; 90():118-123. PubMed ID: 34275534
[TBL] [Abstract][Full Text] [Related]
15. Which risk factors are more associated with ischemic stroke than intracerebral hemorrhage in patients with atrial fibrillation?
McGrath ER; Kapral MK; Fang J; Eikelboom JW; ó Conghaile A; Canavan M; O'Donnell MJ;
Stroke; 2012 Aug; 43(8):2048-54. PubMed ID: 22618379
[TBL] [Abstract][Full Text] [Related]
16. Racial and Ethnic Differences in the Risk of Ischemic Stroke After Nontraumatic Intracerebral Hemorrhage.
Simonetto M; Sheth KN; Ziai WC; Iadecola C; Zhang C; Murthy SB
Stroke; 2023 Sep; 54(9):2401-2408. PubMed ID: 37462054
[TBL] [Abstract][Full Text] [Related]
17. Recurrent stroke after lobar and deep intracerebral hemorrhage: a hospital-based cohort study.
Weimar C; Benemann J; Terborg C; Walter U; Weber R; Diener HC;
Cerebrovasc Dis; 2011; 32(3):283-8. PubMed ID: 21893981
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cerebrovascular Events in Intracerebral Hemorrhage Survivors With Atrial Fibrillation: A Nationwide Cohort Study.
Nielsen PB; Melgaard L; Overvad TF; Jensen M; Larsen TB; Lip GYH;
Stroke; 2022 Aug; 53(8):2559-2568. PubMed ID: 35414198
[TBL] [Abstract][Full Text] [Related]
19. Prior intracerebral hemorrhage and white matter hyperintensity burden on recurrent stroke risk.
Park JH; Kwon SU; Kwon HS; Heo SH
Sci Rep; 2021 Aug; 11(1):17406. PubMed ID: 34465828
[TBL] [Abstract][Full Text] [Related]
20. Blood Pressure Control Targets and Risk of Cardiovascular and Cerebrovascular Events After Intracerebral Hemorrhage.
Teo KC; Keins S; Abramson JR; Leung WCY; Leung IYH; Wong YK; Yeung C; Kourkoulis C; Warren AD; Chan KH; Cheung RTF; Ho SL; Gurol ME; Viswanathan A; Greenberg SM; Anderson CD; Lau KK; Rosand J; Biffi A
Stroke; 2023 Jan; 54(1):78-86. PubMed ID: 36321455
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
